July 14, 2015
GAITHERSBURG, Md. -- OpGen, Inc. (NASDAQ:OPGN) today announced the closing of a $6 million financing by the Merck Global Health Innovation Fund (Merck GHI). In connection with this financing, David M. Rubin, Ph.D., Managing Director of Merck GHI, has been appointed to OpGen's board of directors, effective immediately. Evan Jones, chairman and chief executive officer [...]
July 14, 2015
North Brunswick, NJ – Distek, Inc., an industry leader in pharmaceutical laboratory testing instruments, accessories and validation services, is excited to release an “optional” wireless in-shaft temperature control for the Model 2500 dissolution instrument. The “patent pending” wireless in-shaft temperature sensors offer continuous vessel temperature control and monitoring from within the vessel without the need [...]
July 14, 2015
LOS OSOS, Calif. -- Discovery Life Sciences, Inc., a provider of essential clinical research products and services to the Life Sciences industry announced today that it has launched Magellan – an innovative online ordering platform for ready-to-deliver Human Biospecimens designed for Biopharmaceutical, Biotechnology and Medical Device companies who seek to validate the performance of new [...]
KeyGene and GENALICE report significant mutual benefits of their partnership
July 14, 2015
Molecular genetics Ag Biotech company KeyGene and biomedical big data solutions company GENALICE, jointly mark the significant mutual benefits of their first two years of partnership, running GENALICE MAP in full production as their preferred tool for primary (Next-Generation Sequencing (NGS) data analysis. KeyGene supports its customers and partners with cutting edge breeding technologies and [...]
Neogen launches ELISA test for ‘bath salts’
July 14, 2015
LEXINGTON, Ky. — Neogen has introduced an ELISA screening test that offers ultrasensitive detection of synthetic cathinones, including methcathinone, methylone and mephedrone, and their metabolites. These drugs are commonly marketed as “bath salts” or “plant food.” Neogen’s new simple, sensitive Synthetic Cathinones (Methcathinone) ELISA test kit has been validated for use with whole blood, serum [...]
Transgenomic Launches Most Comprehensive Genetic Test for Diagnosis of Leukodystrophy
July 14, 2015
OMAHA, Neb. — Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing precision medicine through advanced diagnostic tests and clinical and research services, today announced the launch of the Transgenomic Leukodystrophy NGS Panel for the diagnosis of leukodystrophy, a group of rare progressive genetic disorders that affect the central nervous system by disrupting the growth [...]
Luminex Corporation Submits FDA 510(k) Submissions for ARIES™ System and ARIES™ HSV 1&2 Assay
July 14, 2015
AUSTIN, Texas -- Luminex Corporation (NASDAQ: LMNX) today announced that it has submitted 510(k) applications to the FDA for the company's ARIES™ System and ARIES™ HSV 1&2 Assay. The company anticipates receiving FDA clearance and CE-IVD marking before the end of the year. "The FDA submission for the ARIES platform represents the culmination of years [...]
July 14, 2015
Santa Clara, CA -- Park Systems, a leader in Atomic Force Microscopy (AFM) since 1997 is now shippingPark SmartScan, powerful and first of a kind AFM nanoscopic tool that drastically boosts productivity by creating point and click reliable nanoscale images. The new SmartScan operating software for Park AFM systems revolutionizes Atomic Force Microscopy by automatizing [...]
CORIO™ – New generation of laboratory circulators by JULABO
July 14, 2015
ALLENTOWN, PA -- In 1926, the history began with the invention of the glass thermometer by the father of company's founder, Gerhard Juchheim. The new CORIO™ series continues this tradition. These completely redesigned instruments mark yet another milestone in JULABO´s success and its multi-decade history. CORIO™ circulators from JULABO simplify daily work and routine tasks [...]
Collaboration Addresses A Critical Need in Biopharmaceutical Industry
July 14, 2015
SINGAPORE –– Agilent Technologies Inc. (NYSE: A) and the Bioprocessing Technology Institute (BTI), a research institute of Singapore’s Agency for Science, Technology and Research (A*STAR) today announced that they will collaborate on new analytical approaches to analyzing specific protein-linked sugar compounds. The collaboration will address a gap in analytical tests and standards applied for drugs [...]
